X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
cystic fibrosis (124) 124
index medicus (121) 121
humans (108) 108
f508del-cftr (101) 101
cystic fibrosis transmembrane conductance regulator - genetics (86) 86
mutation (80) 80
cystic fibrosis - genetics (66) 66
respiratory system (65) 65
transmembrane conductance regulator (59) 59
cystic fibrosis transmembrane conductance regulator - metabolism (55) 55
cystic fibrosis - drug therapy (54) 54
in-vitro (52) 52
ivacaftor (52) 52
cftr (50) 50
f508del-cftr mutation (49) 49
cystic-fibrosis (38) 38
cystic fibrosis - metabolism (37) 37
animals (34) 34
biochemistry & molecular biology (33) 33
pharmacology & pharmacy (32) 32
lumacaftor (30) 30
cftr potentiator (27) 27
cystic fibrosis transmembrane conductance regulator (27) 27
efficacy (27) 27
g551d mutation (26) 26
aminophenols - therapeutic use (25) 25
proteins (25) 25
quinolones - therapeutic use (25) 25
cell biology (23) 23
protein (23) 23
male (22) 22
rescue (22) 22
correctors (21) 21
cystic fibrosis - physiopathology (20) 20
vx-809 (20) 20
adult (19) 19
cell line (19) 19
congenital, hereditary, and neonatal diseases and abnormalities (18) 18
female (18) 18
safety (18) 18
cystic fibrosis transmembrane conductance regulator - chemistry (17) 17
potentiator (17) 17
small-molecule correctors (17) 17
aminophenols - pharmacology (16) 16
epithelial cells - metabolism (16) 16
identification (16) 16
phe508del cftr (16) 16
quinolones - pharmacology (16) 16
benzodioxoles - pharmacology (15) 15
cystic fibrosis - pathology (15) 15
delta-f508 cftr (15) 15
epithelial-cells (15) 15
fibrosis (15) 15
respiratory tract diseases (15) 15
trafficking (15) 15
adolescent (14) 14
benzodioxoles - therapeutic use (14) 14
cell membrane - metabolism (14) 14
chloride (14) 14
chloride channel (14) 14
cystic fibrosis - therapy (14) 14
pediatrics (14) 14
plasma-membrane (14) 14
aged 6-11 years (13) 13
aminopyridines - pharmacology (13) 13
aminopyridines - therapeutic use (13) 13
child (13) 13
clinical trials (13) 13
double-blind (13) 13
genetic aspects (13) 13
health aspects (13) 13
life sciences (13) 13
pharmacology (13) 13
vx-770 (13) 13
article (12) 12
cells (12) 12
conductance (12) 12
disease (12) 12
endoplasmic-reticulum (12) 12
mice (12) 12
randomized controlled-trial (12) 12
young adult (12) 12
corrector (11) 11
drug therapy (11) 11
personalized medicine (11) 11
aminophenols - adverse effects (10) 10
cftr modulators (10) 10
digestive system diseases (10) 10
drug combinations (10) 10
patients (10) 10
quality-control (10) 10
quinolones - adverse effects (10) 10
resistance (10) 10
abridged index medicus (9) 9
aminophenols - administration & dosage (9) 9
analysis (9) 9
channel (9) 9
epithelial cells - drug effects (9) 9
f508del-cftr trafficking (9) 9
gene (9) 9
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Nature Medicine, ISSN 1078-8956, 2013, Volume 19, Issue 7, pp. 939 - 945
Journal Article
Journal Article
Journal of Asthma, ISSN 0277-0903, 08/2018, Volume 55, Issue 8, pp. 837 - 843
Objective: The F508del mutation occurs in approximately 3.5% of Caucasian population of Northern Europe. Heterozygotes have increased risk for asthma and... 
ABPA | gene mutations | F508del CFTR | LUMACAFTOR | PULMONARY ASPERGILLOSIS | IVACAFTOR | ALLERGY | RESPIRATORY SYSTEM | INFLAMMATION | PHE508DEL CFTR | CYSTIC-FIBROSIS
Journal Article
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 11/2017, Volume 377, Issue 21, pp. 2013 - 2023
Patients with homozygous Phe508del cystic fibrosis were assigned to receive combination tezacaftor–ivacaftor or placebo for 24 weeks. The combination resulted... 
G551D MUTATION | MEDICINE, GENERAL & INTERNAL | IN-VITRO | LUMACAFTOR | EFFICACY | SAFETY | AGED 6-11 YEARS | F508DEL-CFTR | PHASE-3 | CFTR POTENTIATOR | COMBINATION | Proteins | Clinical trials | Cystic fibrosis | Mutation | Drug therapy | Patients | Drug dosages | Quality of life | Pharmaceuticals | Index Medicus | Abridged Index Medicus
Journal Article
Current Drug Targets, ISSN 1389-4501, 09/2016, Volume 17, Issue 11, pp. 1275 - 1281
Journal Article